Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001144204-17-019315
Filing Date
2017-04-06
Accepted
2017-04-06 07:01:12
Documents
4

Document Format Files

Seq Description Document Type Size
1 F-1/A v463696_f1a.htm F-1/A 36603
2 EXHIBIT 5.2 v463696_ex5-2.htm EX-5.2 10865
3 GRAPHIC image_003.jpg GRAPHIC 18238
4 GRAPHIC image_001.jpg GRAPHIC 20642
  Complete submission text file 0001144204-17-019315.txt   102386
Mailing Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042
Business Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042 972 (0) 3 7326616
Bioblast Pharma Ltd. (Filer) CIK: 0001596812 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-216238 | Film No.: 17744396
SIC: 2834 Pharmaceutical Preparations